+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Yellow Fever Drug"

Yellow Fever - Pipeline Insight, 2024 - Product Thumbnail Image

Yellow Fever - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
From
Yellow Fever - Epidemiology Forecast - 2032 - Product Thumbnail Image

Yellow Fever - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Yellow Fever - Pipeline Review, H2 2020 - Product Thumbnail Image

Yellow Fever - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 71 Pages
  • Global
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

The Yellow Fever Drug market is a subset of the larger Infectious Diseases Drugs market. It is composed of drugs used to treat and prevent yellow fever, a viral infection spread by mosquitoes. These drugs are typically administered as a single dose and are effective in preventing the disease in most cases. Vaccines are the most common form of yellow fever drug, although antiviral medications are also available. Vaccines are typically administered to travelers visiting areas where yellow fever is endemic, as well as to those living in areas where the disease is common. The Yellow Fever Drug market is highly competitive, with a number of companies offering products. These include Sanofi Pasteur, GlaxoSmithKline, Merck, and Johnson & Johnson. Other companies, such as Bharat Biotech, have recently entered the market with their own vaccines. Show Less Read more